XC
RMD icon

XY Capital’s ResMed RMD Stock Holding History

XY Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,492
Closed -$4.94M – 265
2025
Q4 		$4.94M Buy
+20,492
New +$5.24M 3.11% 4
2025
Q3 		– Sell
-14,624
Closed -$3.77M – 165
2025
Q2 		$3.77M Buy
+14,624
New +$3.49M 2.6% 12
2024
Q4 		– Sell
-12,111
Closed -$2.96M – 216
2024
Q3 		$2.96M Sell
12,111
-11,628
-49% -$2.6M 1.01% 21
2024
Q2 		$4.54M Buy
+23,739
New +$4.82M 2.87% 6
2024
Q1 		– Sell
-74,580
Closed -$12.8M – 98
2023
Q4 		$12.8M Sell
74,580
-16,884
-18% -$2.59M 7.49% 1
2023
Q3 		$13.5M Buy
91,464
+90,147
+6,845% +$16.3M 7.76% 1
2023
Q2 		$288K Buy
+1,317
New +$294K 0.21% 82

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XY Capital's RMD Position: Q1 2026 in Review

XY Capital sold out of ResMed (RMD) in Q1 2026, closing a stake of 20,492 shares — an estimated $4.94M sold.

XY Capital first reported a position in RMD in Q2 2023 and held it in 7 quarters. The position peaked at $13.5M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • XY Capital reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • XY Capital sold 20,492 ResMed shares in Q1 2026, an estimated $4.94M.
  • XY Capital first reported a position in ResMed in Q2 2023 and held it in 7 quarters.
  • XY Capital's ResMed position peaked at $13.5M in Q3 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on XY Capital's 13F filing for Q1 2026, filed 12 May 2026.